12:00 AM
Oct 25, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Z-92: Began Phase I/II testing

Psoraya Pharmaceuticals Ltd., Orlando, Fla.
Product: Z-92
Business: Autoimmune/Inflammation

Read the full 43 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >